Crisaborole



Product name: Crisaborole

Domestic Registration Status: Registered Y20230000985 I
International Registration Status: DMF

Alias: 4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrileAN2728;AN-2728,>=98%;AN2728,Crisaborole;Crisaborole(AN2728) AN2728;AN2728/AN-2728;4-((1-Hydroxy-1,3-dihydrobenzo-[c][1,2]oxaborol-5-yl)oxy)benzonitrile;4-[(1,3-Dihydro-1-hydroxy-2,1- 4-[(1,3-Dihydro-1-hydroxy-2,1- benzoxaborol-5-yl)oxy]benzonitrile

CAS No.: 906673-24-3
Molecular Formula: C14H10BNO3
Molecular weight: 251.05
EINECS No.: 250-635-4
Appearance: White or off-white crystalline powder
Usage: Used as intermediate of dermatological drugs.
Product specification: 0.5kg/barrel, 1kg/barrel, 2kg/barrel, 3kg/barrel, 4kg/barrel, 5kg/barrel, 6kg/barrel, 7kg/barrel, 8kg/barrel, 9kg/barrel, 10kg/barrel, etc., and it can be separately subcontracted according to the requirements of customers.

Price: Price is for reference only, call us for one-to-one quotation.





Cliborol Upstream and downstream product information

Upstream raw materials: 2-hydroxymethyl-5-hydroxyphenylboronic acid half ester p-fluorobenzonitrile





Advantageous products


Vonorazan and its intermediates, dagliflozin and its intermediates, Clevoborol and its intermediates, Letemovir and its intermediates, Mildronate, Veterinary products (intermediates of floretanol, aflatanol and sarolanol and other intermediates), Ropivacaine Hydrochloride and its intermediates, local anesthesia series (Lidocaine Hydrochloride, Lidocaine, Propamocaine Hydrochloride, Proparacaine, Butocaine Hydrochloride, and so on) and etc., which cover the areas of cardio-cerebral and cerebral vascular, neurological, anti-tumor, and local anesthesia. , anti-tumor, local anesthesia and other fields. Our main advantages are high quality products, reasonable price, fast delivery and attentive after-sales service, and we support customized products.



Other related products

Return

Copyright 2018 Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. All Rights Reserved Lu ICP 18055647